Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas
- PMID: 20453661
- DOI: 10.1097/MCG.0b013e3181d8fb91
Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas
Abstract
Goals: The predictors of malignant intraductal papillary mucinous neoplasm (IPMN) and invasive IPMN were investigated in this study to determine the optimal indicators of surgical resection for IPMN.
Background: Recently, international consensus guidelines have described the standard indicators of resection for IPMN. However, the indicators of surgical resection for IPMN, especially for branch duct IPMN, still remain controversial.
Study: Eighty-two patients with IPMN who underwent surgical resection during April 1998 to January 2009, were retrospectively reviewed and examined with regard to their preoperative factors and pathologic diagnosis.
Results: Multivariate analysis showed that main duct IPMN (P<0.01) and earlier diabetes (P=0.03) were independent predictors of malignant IPMN. In branch duct IPMN, the diameter of the main pancreatic duct (MPD) was found to be significantly associated with malignancy by univariate analysis (P=0.034). An elevated serum CA19-9 level (P<0.01) was an independent predictor of invasive IPMN.
Conclusions: Our observations suggest that main duct IPMN, branch duct IPMN with MPD dilatation, and IPMN with an elevated serum CA19-9 level should be considered as indications for surgical resection.
Similar articles
-
Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.Hepatogastroenterology. 2010 May-Jun;57(99-100):635-9. Hepatogastroenterology. 2010. PMID: 20698241
-
Predicting malignant intraductal papillary mucinous neoplasm: a single-center review.Am J Surg. 2011 May;201(5):575-9. doi: 10.1016/j.amjsurg.2011.01.003. Am J Surg. 2011. PMID: 21545902
-
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639. Arch Surg. 2008. PMID: 18645105
-
[Intraductal papillary mucinous neoplasm of the pancreas, IPMN].Duodecim. 2013;129(6):591-8. Duodecim. 2013. PMID: 23614224 Review. Finnish.
-
[Surgical management of intraductal papillary mucinous neoplasms].Korean J Gastroenterol. 2008 Oct;52(4):220-5. Korean J Gastroenterol. 2008. PMID: 19077523 Review. Korean.
Cited by
-
Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors.Arch Med Sci. 2013 Aug 30;9(4):677-83. doi: 10.5114/aoms.2013.36899. Epub 2013 Aug 8. Arch Med Sci. 2013. PMID: 24049528 Free PMC article.
-
Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.Endosc Int Open. 2016 Dec;4(12):E1228-E1235. doi: 10.1055/s-0042-117216. Epub 2016 Nov 10. Endosc Int Open. 2016. PMID: 27995180 Free PMC article.
-
Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know.Ther Adv Gastrointest Endosc. 2021 Sep 23;14:26317745211045769. doi: 10.1177/26317745211045769. eCollection 2021 Jan-Dec. Ther Adv Gastrointest Endosc. 2021. PMID: 34589706 Free PMC article. Review.
-
Malignant infiltrating intraductal papillary mucinous neoplasm with internal fistula: one case report and clinical practice.Int J Clin Exp Med. 2015 Nov 15;8(11):21732-6. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885135 Free PMC article.
-
What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.Clin Transl Gastroenterol. 2015 Dec 10;6(12):e130. doi: 10.1038/ctg.2015.60. Clin Transl Gastroenterol. 2015. PMID: 26658837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous